Entity
  • Evaluate Ltd

    Created in 1996
  • BETA

    Up & running (A)
    Existing signals show a regular activity
  • Social networks

    24,177 3,608 22,938
  • Activities

  • Technologies

  • Entity types

  • Location

    3 More London Riverside, 3 More London Pl, London SE1 2RE, UK

    London

    United Kingdom

  • Employees

    Scale: 51-200

    Estimated: 197

  • Engaged corporates

    7
    1 5
  • Added in Motherbase

    5 years, 4 months ago
Description
  • Value proposition

    Evaluate provides trusted commercial intelligence and predictive analytics to the pharmaceutical industry

    Evaluate provides trusted commercial intelligence and predictive analytics for the pharmaceutical industry. We help our clients to refine and transform their understanding of the past, present and future of the global pharmaceutical market to drive better decisions.

    Evaluate solutions give you the time and confidence to turn understanding into insight, and insight into action:

    Evaluate Omnium - provides a complete, dynamic view of development risk and commercial return across the full clinical lifecycle, delivering game-changing insight into pharma asset potential.

    EvaluatePharma - the trusted global view of the pharmaceutical market’s past, present and future performance with consensus forecasts to 2026, company financials, pipelines, deals and more. @EvaluatePharma

    EvaluateMedTech - tracks, benchmarks, and forecasts global performance for the medical device and diagnostic industry with consensus forecasts to 2024, company financials and more.

    Evaluate Custom Solutions - improve your strategic decision-making with customised solutions and deep insights that draw on our industry expertise and trusted commercial intelligence.

    Explore Evaluate at www.evaluate.com
    Twitter: @EvaluatePharma




    pharma business analysis, pharma licensing deals, pharma consensus forecasts, biotech business analysis, pharma competitive intelligence, medtech consensus forecasts, pharma business developement, pharma, biotech, medtech news, pharma R&D analysis, and pharma data

  • Pharma commercial intelligence, news & analysis | Evaluate

    Trusted commercial intelligence, consensus forecasts, Vantage news and analysis for pharma, biotech and medtech industry - Explore Evaluate

  • https://www.evaluate.com/
Corporate interactions BETA
Corporate TypeTweets Articles
MSD
MSD
Pharmaceutical, Pharmaceutical Manufacturing
MSD
Pharmaceutical, Pharmaceutical Manufacturing
Other

30 Nov 2018


Sofinnova Partners
Sofinnova Partners
Financial Services
Sofinnova Partners
Financial Services
Other

30 Jan 2023


Johnson & Johnson
Johnson & Johnson
Pharmaceutical, Hospitals and Health Care
Johnson & Johnson
Pharmaceutical, Hospitals and Health Care
Other

31 May 2018


Bayer
Bayer
Pharmaceutical, Chemistry, Chemical Manufacturing
Bayer
Pharmaceutical, Chemistry, Chemical Manufacturing
Other

13 Jan 2021


Gilead Sciences
Gilead Sciences
Pharmaceutical, Biotechnology, Biotechnology Research
Gilead Sciences
Pharmaceutical, Biotechnology, Biotechnology Research
Capitalistic
Not partnership
Not event

6 Feb 2019

29 Jul 2022



Financial Times
Financial Times
Media, Newspaper Publishing
Financial Times
Media, Newspaper Publishing
Other

22 Feb 2021


Moderna
Moderna
Pharmaceutical, Biotechnology, Biotechnology Research
Moderna
Pharmaceutical, Biotechnology, Biotechnology Research
Not capitalistic
Not partnership
Event

28 Apr 2020


Similar entities
Loading...
Loading...
Social network dynamics